Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.11 Million USD | -22.3% |
| 2022 | 2.72 Million USD | 12.69% |
| 2021 | 2.41 Million USD | 11.27% |
| 2020 | 2.17 Million USD | -32.69% |
| 2019 | 3.23 Million USD | 14.95% |
| 2018 | 2.81 Million USD | 4.66% |
| 2017 | 2.68 Million USD | -45.34% |
| 2016 | 4.91 Million USD | 14.9% |
| 2015 | 4.27 Million USD | -4.26% |
| 2014 | 4.46 Million USD | 8.93% |
| 2013 | 4.09 Million USD | 54.68% |
| 2012 | 2.65 Million USD | 28.14% |
| 2011 | 2.06 Million USD | 11.42% |
| 2010 | 1.85 Million USD | 6.79% |
| 2009 | 1.73 Million USD | -6.61% |
| 2008 | 1.86 Million USD | 3.68% |
| 2007 | 1.79 Million USD | -39.72% |
| 2006 | 2.97 Million USD | 5.16% |
| 2005 | 2.83 Million USD | -8.62% |
| 2004 | 3.09 Million USD | 29.99% |
| 2003 | 2.38 Million USD | 4.61% |
| 2002 | 2.27 Million USD | 64.55% |
| 2001 | 1.38 Million USD | 69.73% |
| 2000 | 816 Thousand USD | 60.63% |
| 1999 | 508 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.27 Million USD | 7.41% |
| 2024 Q2 | 2.41 Million USD | 6.2% |
| 2023 Q3 | 3.03 Million USD | 4.29% |
| 2023 Q1 | 2.8 Million USD | 3.04% |
| 2023 Q2 | 2.91 Million USD | 3.7% |
| 2023 Q4 | 2.11 Million USD | -30.28% |
| 2023 FY | 2.11 Million USD | -22.3% |
| 2022 Q1 | 2.5 Million USD | 3.39% |
| 2022 FY | 2.72 Million USD | 12.69% |
| 2022 Q3 | 2.66 Million USD | 2.74% |
| 2022 Q4 | 2.72 Million USD | 2.37% |
| 2022 Q2 | 2.59 Million USD | 3.64% |
| 2021 Q4 | 2.41 Million USD | 0.08% |
| 2021 Q1 | 2.27 Million USD | 4.51% |
| 2021 Q2 | 2.33 Million USD | 2.55% |
| 2021 Q3 | 2.41 Million USD | 3.73% |
| 2021 FY | 2.41 Million USD | 11.27% |
| 2020 Q2 | 3.35 Million USD | 1.36% |
| 2020 FY | 2.17 Million USD | -32.69% |
| 2020 Q1 | 3.31 Million USD | 2.6% |
| 2020 Q4 | 2.17 Million USD | -36.95% |
| 2020 Q3 | 3.44 Million USD | 2.65% |
| 2019 Q3 | 3.07 Million USD | 2.47% |
| 2019 Q2 | 2.99 Million USD | 0.37% |
| 2019 Q1 | 2.98 Million USD | 6.33% |
| 2019 FY | 3.23 Million USD | 14.95% |
| 2019 Q4 | 3.23 Million USD | 5.11% |
| 2018 Q1 | 2.72 Million USD | 1.49% |
| 2018 FY | 2.81 Million USD | 4.66% |
| 2018 Q3 | 2.8 Million USD | -6.69% |
| 2018 Q4 | 2.81 Million USD | 0.25% |
| 2018 Q2 | 3 Million USD | 10.24% |
| 2017 FY | 2.68 Million USD | -45.34% |
| 2017 Q4 | 2.68 Million USD | 13.48% |
| 2017 Q2 | 2.45 Million USD | -25.1% |
| 2017 Q1 | 3.27 Million USD | -33.25% |
| 2017 Q3 | 2.36 Million USD | -3.66% |
| 2016 Q1 | 4.43 Million USD | 3.74% |
| 2016 Q3 | 5.03 Million USD | 7.9% |
| 2016 Q4 | 4.91 Million USD | -2.52% |
| 2016 FY | 4.91 Million USD | 14.9% |
| 2016 Q2 | 4.67 Million USD | 5.3% |
| 2015 Q3 | 4.03 Million USD | -14.06% |
| 2015 Q2 | 4.69 Million USD | 3.16% |
| 2015 Q1 | 4.55 Million USD | 1.93% |
| 2015 Q4 | 4.27 Million USD | 5.95% |
| 2015 FY | 4.27 Million USD | -4.26% |
| 2014 FY | 4.46 Million USD | 8.93% |
| 2014 Q1 | 4.64 Million USD | 13.37% |
| 2014 Q2 | 4.69 Million USD | 1.01% |
| 2014 Q3 | 4.46 Million USD | -4.88% |
| 2014 Q4 | 4.46 Million USD | 0.0% |
| 2013 FY | 4.09 Million USD | 54.68% |
| 2013 Q3 | 3.9 Million USD | 6.03% |
| 2013 Q4 | 4.09 Million USD | 5.02% |
| 2013 Q2 | 3.68 Million USD | 30.25% |
| 2013 Q1 | 2.82 Million USD | 6.64% |
| 2012 Q4 | 2.65 Million USD | -2.61% |
| 2012 Q3 | 2.72 Million USD | -3.68% |
| 2012 Q2 | 2.82 Million USD | 9.71% |
| 2012 Q1 | 2.57 Million USD | 24.52% |
| 2012 FY | 2.65 Million USD | 28.14% |
| 2011 Q4 | 2.06 Million USD | 11.78% |
| 2011 Q2 | 2.06 Million USD | -6.72% |
| 2011 Q1 | 2.21 Million USD | 19.45% |
| 2011 FY | 2.06 Million USD | 11.42% |
| 2011 Q3 | 1.85 Million USD | -10.54% |
| 2010 Q2 | 1.84 Million USD | 0.16% |
| 2010 Q4 | 1.85 Million USD | -6.73% |
| 2010 Q3 | 1.99 Million USD | 7.68% |
| 2010 FY | 1.85 Million USD | 6.79% |
| 2010 Q1 | 1.84 Million USD | 6.16% |
| 2009 Q4 | 1.73 Million USD | -5.18% |
| 2009 FY | 1.73 Million USD | -6.61% |
| 2009 Q1 | 1.81 Million USD | -2.74% |
| 2009 Q2 | 1.81 Million USD | 0.33% |
| 2009 Q3 | 1.83 Million USD | 0.94% |
| 2008 Q3 | 1.78 Million USD | -1.38% |
| 2008 Q2 | 1.81 Million USD | 5.1% |
| 2008 FY | 1.86 Million USD | 3.68% |
| 2008 Q1 | 1.72 Million USD | -3.96% |
| 2008 Q4 | 1.86 Million USD | 4.14% |
| 2007 Q1 | 3.04 Million USD | 2.18% |
| 2007 FY | 1.79 Million USD | -39.72% |
| 2007 Q4 | 1.79 Million USD | -56.07% |
| 2007 Q3 | 4.08 Million USD | 8.12% |
| 2007 Q2 | 3.77 Million USD | 24.19% |
| 2006 Q3 | 3.09 Million USD | 2.14% |
| 2006 Q4 | 2.97 Million USD | -3.87% |
| 2006 Q1 | 2.89 Million USD | 2.3% |
| 2006 Q2 | 3.03 Million USD | 4.69% |
| 2006 FY | 2.97 Million USD | 5.16% |
| 2005 Q1 | 3.12 Million USD | 0.77% |
| 2005 Q2 | 3.14 Million USD | 0.83% |
| 2005 FY | 2.83 Million USD | -8.62% |
| 2005 Q3 | 3.4 Million USD | 8.13% |
| 2005 Q4 | 2.83 Million USD | -16.83% |
| 2004 FY | 3.09 Million USD | 29.99% |
| 2004 Q3 | 2.73 Million USD | 8.19% |
| 2004 Q2 | 2.52 Million USD | 12.66% |
| 2004 Q1 | 2.24 Million USD | -5.91% |
| 2004 Q4 | 3.09 Million USD | 13.35% |
| 2003 Q1 | 1.95 Million USD | -14.26% |
| 2003 Q2 | 1.96 Million USD | 0.72% |
| 2003 FY | 2.38 Million USD | 4.61% |
| 2003 Q4 | 2.38 Million USD | 12.19% |
| 2003 Q3 | 2.12 Million USD | 7.98% |
| 2002 FY | 2.27 Million USD | 64.55% |
| 2002 Q1 | 1.44 Million USD | 4.4% |
| 2002 Q2 | 1.39 Million USD | -3.53% |
| 2002 Q3 | 1.59 Million USD | 14.34% |
| 2002 Q4 | 2.27 Million USD | 42.88% |
| 2001 Q4 | 1.38 Million USD | 28.0% |
| 2001 Q3 | 1.08 Million USD | 37.31% |
| 2001 Q1 | 960 Thousand USD | 17.65% |
| 2001 FY | 1.38 Million USD | 69.73% |
| 2001 Q2 | 788 Thousand USD | -17.92% |
| 2000 Q2 | 382 Thousand USD | -17.14% |
| 2000 Q4 | 816 Thousand USD | 17.58% |
| 2000 Q3 | 694 Thousand USD | 81.68% |
| 2000 Q1 | 461 Thousand USD | 0.0% |
| 2000 FY | 816 Thousand USD | 60.63% |
| 1999 FY | 508 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 81.731% |
| BioElectronics Corporation | 16.62 Million USD | 87.258% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -234.069% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -212.566% |
| Polarean Imaging plc | 2.58 Million USD | 17.924% |
| AVITA Medical, Inc. | 19.86 Million USD | 89.338% |
| Össur hf. | 688.8 Million USD | 99.693% |
| Zecotek Photonics Inc. | 5.86 Million USD | 63.91% |
| QHSLab, Inc. | 2.05 Million USD | -2.963% |
| Wellstar International, Inc. | 55.99 Million USD | 96.217% |
| Össur hf. | 688.8 Million USD | 99.693% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 86.829% |
| Escalon Medical Corp. | 2.94 Million USD | 28.163% |
| Aurora Spine Corporation | 6.65 Million USD | 68.167% |
| BrainsWay Ltd. | 15.31 Million USD | 86.17% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 64.774% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 95.38% |
| Vivos Inc. | 245 Thousand USD | -764.476% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.915% |
| Kelyniam Global, Inc. | 1.01 Million USD | -109.095% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -668.466% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 13.544% |
| Nanomix Corporation | 14.81 Million USD | 85.703% |
| Theraclion SA | 13.01 Million EUR | 83.728% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 58.667% |
| Positron Corporation | 2.02 Million USD | -4.541% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 41.511% |
| Lombard Medical, Inc. | 53.79 Million USD | 96.063% |
| ALR Technologies Inc. | 24.5 Million USD | 91.357% |
| Stratec SE | 271.97 Million USD | 99.221% |
| Vycor Medical, Inc. | 4.31 Million USD | 50.947% |
| Heart Tronics, Inc. | 1.09 Million USD | -93.462% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 10.208% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 61.326% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 96.771% |
| VMS Rehab Systems, Inc. | 201.36 USD | -1051747.437% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 61.315% |
| Ingen Technologies, Inc. | 5.7 Million USD | 62.904% |
| Odyssey Group International, Inc. | 6.61 Million USD | 67.966% |
| United American Healthcare Corporation | 119 Thousand USD | -1679.832% |
| ECGI Holdings, Inc. | 11.94 Million USD | 82.262% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -59.972% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -46.439% |
| Urologix, Inc. | 12.64 Million USD | 83.249% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 60.749% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 75.031% |
| SS Innovations International, Inc. | 11.18 Million USD | 81.057% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -303.131% |
| Smith & Nephew plc | 4.76 Billion USD | 99.956% |
| NIOX Group Plc | 9.8 Million USD | 78.392% |
| Fuse Medical, Inc. | 15.11 Million USD | 85.983% |
| Broncus Holding Corporation | 10.43 Million USD | 79.697% |
| Brain Scientific Inc. | 7.42 Million USD | 71.48% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 93.734% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -166.723% |